Origene Overview
- Year Founded
-
1996
- Status
-
Acquired/Merged
- Latest Deal Type
-
Debt - PPP
- Latest Deal Amount
-
$1.02M
Origene General Information
Description
Provider of gene-centric research tools for the pharmaceutical and biotechnology sectors designed to develop genome-wide knockout cells from commonly used laboratory cell lines. The company's research tools develop and sell cDNA clone collection, a searchable gene bank of human full-length TrueClone cDNA collection and TrueORF cDNA clones, thereby enabling pharmaceutical, biotechnology and academic research companies to validate antibodies and develop new drugs.
Contact Information
Website
www.origene.com(Operating Subsidiary)
Corporate Office
- 9620 Medical Center Drive
- Suite 200
- Rockville, MD 20850
- United States
Corporate Office
- 9620 Medical Center Drive
- Suite 200
- Rockville, MD 20850
- United States
Origene Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Debt - PPP | 06-May-2020 | $1.02M | Completed | Generating Revenue | ||
| 10. Merger/Acquisition | 13-Feb-2017 | Completed | Generating Revenue | |||
| 9. Secondary Transaction - Private | 01-Dec-2016 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 09-Jun-2015 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 10-Mar-2014 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series C) | 19-Mar-2013 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B) | 18-Mar-2010 | Completed | Product Development | |||
| 4. Secondary Transaction - Private | 01-May-2009 | Completed | Startup | |||
| 3. Grant | 01-Jan-2005 | $391K | Completed | Startup | ||
| 2. Grant | 01-Jan-2000 | $314K | Completed | Startup |
Origene Comparisons
Industry
Financing
Details
Origene Competitors (16)
One of Origene’s 16 competitors is CIS Bio International, a Formerly PE-Backed company based in Saclay, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CIS Bio International | Formerly PE-Backed | Saclay, France | ||||
| ProSci (Biotechnology) | Private Equity-Backed | Poway, CA | ||||
| Molecular Cloning Laboratories | Corporation | South San Francisco, CA | ||||
| Abcam | Corporate Backed or Acquired | Cambridge, United Kingdom | ||||
| Twist Bioscience | Formerly VC-backed | South San Francisco, CA |
Origene Patents
Origene Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2010298238-A1 | Protein arrays and uses thereof | Inactive | 25-Sep-2009 | ||
| CA-2774615-A1 | Protein arrays and uses thereof | Inactive | 25-Sep-2009 | ||
| EP-2480892-A1 | Protein arrays and uses thereof | Inactive | 25-Sep-2009 | ||
| US-20120231969-A1 | Protein arrays and uses thereof | Inactive | 25-Sep-2009 | ||
| WO-2011038138-A1 | Protein arrays and uses thereof | Inactive | 25-Sep-2009 | G01N33/68 |
Origene Former Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Accel | Venture Capital | Minority | ||
| BroadOak Capital Partners | Growth/Expansion | Minority | ||
| Cathay Capital | PE/Buyout | Minority | ||
| Emerging Technology Partners (Venture Capital) | Venture Capital | Minority | ||
| IDG Capital | Venture Capital | Minority |
Origene Acquisitions (7)
Origene’s most recent deal was a Merger/Acquisition with Acris Antibodies. The deal was made on 28-Oct-2015.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Acris Antibodies | 28-Oct-2015 | Merger/Acquisition | Distributors (Healthcare) | ||
| BioCheck | 26-Feb-2014 | Merger/Acquisition | Diagnostic Equipment | ||
| Strategic Diagnostics (Life-Science Assets) | 15-Jun-2013 | Merger/Acquisition | Buildings and Property | ||
| SDIX | 08-Apr-2013 | Merger/Acquisition | Biotechnology | ||
| Beijing Zhongshan Golden Bridge Biotechnology | 12-Mar-2012 | Merger/Acquisition | Other Devices and Supplies |
Origene Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| BioCheck | Pleasant Hill, CA | 1997 | |
| SDIX | Newark, DE | 1990 |
Origene FAQs
-
When was Origene founded?
Origene was founded in 1996.
-
Where is Origene headquartered?
Origene is headquartered in Rockville, MD.
-
What industry is Origene in?
Origene’s primary industry is Discovery Tools (Healthcare).
-
Is Origene a private or public company?
Origene is a Private company.
-
What is Origene’s current revenue?
The current revenue for Origene is .
-
How much funding has Origene raised over time?
Origene has raised $54.3M.
-
Who are Origene’s investors?
Accel, BroadOak Capital Partners, Cathay Capital, Emerging Technology Partners (Venture Capital), and IDG Capital are 5 of 13 investors who have invested in Origene.
-
Who are Origene’s competitors?
CIS Bio International, ProSci (Biotechnology), Molecular Cloning Laboratories, Abcam, and Twist Bioscience are some of the 16 competitors of Origene.
-
When was Origene acquired?
Origene was acquired on 06-May-2020.
-
Who acquired Origene?
Origene was acquired by Zhongyuan Union Cell & Gene Engineering Corporation.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process